Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -59.07% is 285% below its 5-year average of -15.33%, near the low end of its 5-year range (-68.76%–63.75%).
As of the fiscal period ended Sunday, June 28, 2026. 14.46% below its 12-month average of -51.61%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-28): -59.07%.
RETURN ON EQUITY (ROE)
-59.07%
RETURN ON EQUITY (ROE) AVG TTM
-51.61%
RETURN ON EQUITY (ROE) AVG 3Y
-42.43%
RETURN ON EQUITY (ROE) AVG 5Y
-15.33%
RETURN ON EQUITY (ROE) AVG 10Y
10.79%
RETURN ON EQUITY (ROE) AVG 15Y
4.39%
RETURN ON EQUITY (ROE) AVG 20Y
8.35%
CURRENT VS TTM AVG
-14.46%
CURRENT VS 3Y AVG
-39.20%
CURRENT VS 5Y AVG
-285.33%
CURRENT VS 10Y AVG
-647.34%
CURRENT VS 15Y AVG
-1444.57%
CURRENT VS 20Y AVG
-807.82%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
-40.60%
vs the sector median at left
QuidelOrtho Corporation
Market Cap
$857.16M
Return on Equity (ROE)
-59.07%
TTM Avg
-51.61%
3Y Avg
-42.43%
5Y Avg
-15.33%
Market Cap
$855.38M
Return on Equity (ROE)
-97.08%
TTM Avg
-96.94%
3Y Avg
-22.72%
5Y Avg
-22.72%
Market Cap
$853.13M
Return on Equity (ROE)
75.67%
TTM Avg
312.76%
3Y Avg
285.83%
5Y Avg
166.15%
Market Cap
$852.35M
Return on Equity (ROE)
-167.25%
TTM Avg
-94.03%
3Y Avg
-58.96%
5Y Avg
-58.96%
Market Cap
$867.03M
Return on Equity (ROE)
-8.03%
TTM Avg
-14.58%
3Y Avg
-29.27%
5Y Avg
-30.82%
Market Cap
$870.81M
Return on Equity (ROE)
N/A
TTM Avg
30.44%
3Y Avg
30.44%
5Y Avg
30.44%
Market Cap
$838.16M
Return on Equity (ROE)
-28.46%
TTM Avg
-48.75%
3Y Avg
-33.66%
5Y Avg
-33.66%
Market Cap
$833.81M
Return on Equity (ROE)
-33.06%
TTM Avg
-24.59%
3Y Avg
-41.17%
5Y Avg
-18.72%
Market Cap
$838.62M
Return on Equity (ROE)
N/A
TTM Avg
-5137.85%
3Y Avg
-2593.82%
5Y Avg
-1731.57%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QuidelOrtho Corporation (QDEL) | $857.16M | -59.07% | -51.61% | -42.43% | -15.33% |
| Alumis Inc. (ALMS)vs › | $855.38M | -97.08% | -96.94% | -22.72% | -22.72% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 75.67% | 312.76% | 285.83% | 166.15% |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | -167.25% | -94.03% | -58.96% | -58.96% |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | -8.03% | -14.58% | -29.27% | -30.82% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | N/A | 30.44% | 30.44% | 30.44% |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | -28.46% | -48.75% | -33.66% | -33.66% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $833.81M | -33.06% | -24.59% | -41.17% | -18.72% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | N/A | -5137.85% | -2593.82% | -1731.57% |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 59.16% | -57.78% | -58.75% | -57.09% |
ROE
-59.1%
ROA
-18.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-28 | -59.07% |
| 2026-03-29 | -65.40% |
| 2025-12-28 | -58.93% |
| 2025-09-28 | -57.92% |
| 2025-06-29 | -16.70% |
| 2025-03-30 | -11.97% |
| 2024-12-29 | -68.76% |
| 2024-09-29 | -58.57% |
| 2024-06-30 | -58.59% |
| 2024-03-31 | -53.36% |
| 2023-12-31 | -0.20% |
| 2023-10-01 | 0.27% |
| 2022-10-02 | 16.89% |
| 2022-07-03 | 20.45% |
| 2022-03-31 | 41.66% |
| 2021-12-31 | 36.50% |
| 2021-09-30 | 54.04% |
| 2021-06-30 | 63.75% |
| 2021-03-31 | 63.65% |
| 2020-12-31 | 60.80% |
| 2020-09-30 | 43.66% |
| 2020-06-30 | 25.29% |
| 2020-03-31 | 14.59% |
| 2019-12-31 | 13.03% |
| 2019-09-30 | 14.00% |
| 2019-06-30 | 13.61% |
| 2019-03-31 | 14.12% |
| 2018-12-31 | 17.43% |
| 2018-09-30 | 9.43% |
| 2018-06-30 | 5.49% |
| 2018-03-31 | 3.48% |
| 2017-12-31 | -3.60% |
| 2017-09-30 | -2.30% |
| 2017-06-30 | -0.03% |
| 2017-03-31 | 1.78% |
| 2016-12-31 | -6.88% |
| 2016-09-30 | -6.22% |
| 2016-06-30 | -6.44% |
| 2016-03-31 | -6.81% |
| 2015-12-31 | -2.78% |
| 2015-09-30 | 0.64% |
| 2015-06-30 | -1.56% |
| 2015-03-31 | -0.62% |
| 2014-12-31 | -2.89% |
| 2014-09-30 | -6.00% |
| 2014-06-30 | -5.30% |
| 2014-03-31 | -2.88% |
| 2013-12-31 | 3.30% |
| 2013-09-30 | 6.89% |
| 2013-06-30 | 8.51% |
| 2013-03-31 | 7.92% |
| 2012-12-31 | 2.50% |
| 2012-09-30 | -1.49% |
| 2012-06-30 | -1.76% |
| 2012-03-31 | -2.03% |
| 2011-12-31 | 4.12% |
| 2011-09-30 | 3.43% |
| 2011-06-30 | 0.83% |
| 2011-03-31 | 1.47% |
| 2010-12-31 | -10.02% |
| 2010-09-30 | 8.33% |
| 2010-06-30 | 25.97% |
| 2010-03-31 | 27.36% |
| 2009-12-31 | 26.00% |
| 2009-09-30 | 15.96% |
| 2009-06-30 | 8.61% |
| 2009-03-31 | 7.01% |
| 2008-12-31 | 15.81% |
| 2008-09-30 | 16.73% |
| 2008-06-30 | 16.55% |
| 2008-03-31 | 15.65% |
| 2007-12-31 | 12.66% |
| 2007-09-30 | 24.38% |
| 2007-06-30 | 25.31% |
| 2007-03-31 | 21.89% |
| 2006-12-31 | 21.03% |
| 2006-09-30 | 15.50% |
| 2006-06-30 | 13.24% |
| 2006-03-31 | 14.88% |
| 2005-12-31 | -10.61% |
| 2005-09-30 | -25.73% |
| 2005-06-30 | -32.81% |
| 2005-03-31 | -33.62% |
| 2004-12-31 | -6.97% |
| 2004-09-30 | 14.68% |
| 2004-06-30 | 17.52% |
| 2004-03-31 | 19.17% |
| 2003-12-31 | 21.89% |
| 2003-09-30 | 2.16% |
| 2003-06-30 | 1.07% |
